Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Damiano de Felice to present the AMR Benchmark at World Water Week in Stockholm

Damiano de Felice, Director of Strategy of the Access to Medicine Foundation, will speak at the World Water Week conference themed “Water, ecosystems and human development.”

Date

27 August 2018

The event, organised by SIWI, will bring together experts, practitioners, decision-makers, business innovators and young professionals from a range of sectors and countries to exchange ideas, foster new thinking and develop solutions to the most pressing water-related challenges.

Damiano will join a session titled “Tackling antimicrobial resistance through safe, clean water and environmental health” to present the Antimicrobial Resistance Benchmark, which is the first independent assessment of pharma company action on antimicrobial resistance, covering antimicrobial R&D, responsible production and appropriate access and stewardship. He will focus on funding and incentive structures developed to strengthen mitigation measures.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved